Published on 28 Feb 2024 on GuruFocus.com via Yahoo Finance
Revenue Growth: Fourth quarter revenue increased by 18% year-over-year, and full year revenue grew by 28%.Gross Profit and Margin: Gross profit improved in Q4, with a slight increase in gross margin; however, full year gross margin slightly decreased.Operating Expenses: Operating expenses rose by 18% in Q4 and 22% for the full year, largely due to increased headcount.Net Loss: Net loss was $13.0 million for Q4 and $55.7 million for the full year, with losses per share slightly improving.Adjusted EBITDA: Adjusted EBITDA showed a reduced loss in both Q4 and the full year compared to the previous year.2024 Financial Outlook: Silk Road Medical projects full year 2024 revenue to be between $194 million and $198 million.Liquidity Position: Cash, cash equivalents, and investments totaled $190.9 million as of December 31, 2023.
Warning! GuruFocus has detected 2 Warning Sign with SILK.
Silk Road Medical Inc (SILK) Reports Growth Amidst Increased Adoption of TCAR